Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
In the last 90 days, Lipocine Inc. insiders filed 1 open-market purchase and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Lipocine Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 49 | 45 | −4 |
| Shares | 10.5M | 10.0M | −508.3K (−4.8%) |
| Value | $4.16M | $3.17M | −$989.6K (−23.8%) |
New holders (6)
Institutions that held Lipocine Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Carson Advisory Inc. | 52,000 | $16.5K | 0.01% |
| Virtu Financial LLC | 20,487 | $7.00K | 0.00% |
| Cornerstone Wealth Management, LLC | 16,000 | $5.09K | 0.00% |
| Azzad Asset Management Inc | 15,000 | $4.77K | 0.00% |
| Caldwell Sutter Capital, Inc. | 8,000 | $2.54K | 0.00% |
| Group One Trading, L.P. | 2,046 | $651 | 0.00% |
Sold out (10)
Institutions that held Lipocine Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Mercer Global Advisors Inc | 159,111 | $63.0K |
| Bailard, Inc. | 82,957 | $31.9K |
| Merit Financial Group, LLC | 29,901 | $11.9K |
| Two Sigma Securities, LLC | 16,796 | $6.68K |
| Plante Moran Financial Advisors, LLC | 17,000 | $6.53K |
| Belvedere Trading LLC | 4,200 | $1.67K |
| Benjamin F. Edwards & Company, Inc. | 1,500 | $1.00K |
| Truvestments Capital LLC | 1,407 | $560 |
| The PNC Financial Services Group, Inc. | 200 | $80 |
| Northwestern Mutual Wealth Management Co | 51 | $20 |